What is the Impact Factor of Nanomedicine-Nanotechnology Biology and Medicine?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Nanomedicine-Nanotechnology Biology and Medicine is 4.30, ranking in quartile Q2 of Web of Science (SCIE).

Is Nanomedicine-Nanotechnology Biology and Medicine indexed in Web of Science or Scopus?

Yes, Nanomedicine-Nanotechnology Biology and Medicine is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.845 (Q1) and an H-index of 166.

Who publishes Nanomedicine-Nanotechnology Biology and Medicine and what is the Article Processing Charge (APC)?

Nanomedicine-Nanotechnology Biology and Medicine is published by Elsevier Inc.. The estimated Article Processing Charge (APC) is approximately $3,275 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Nanomedicine-Nanotechnology Biology and Medicine?

The official ISO-4 abbreviation of Nanomedicine-Nanotechnology Biology and Medicine is "NANOMED-NANOTECHNOL" with common acronym "nano". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #6,376Hybrid

Nanomedicine-Nanotechnology Biology and Medicine

Acronym:nano

•

Abbreviation (ISO):NANOMED-NANOTECHNOL

•

Identifier (ISSN):1549-9634(Print)/1549-9642(Online)

•

Publisher:Elsevier Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

4.3↓ -0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Nanomedicine-Nanotechnology Biology and Medicine

WoS Q2

Annual Impact Factor Metric

Current (2026):4.3

Scopus SJR & RankScopus Q1

0.845

#6,376

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

166

166 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

143articles/year

23.04% Gold OA•97.45% Original Research

Aims & Scope

The mission of Nanomedicine: Nanotechnology, Biology, and Medicine (Nanomedicine: NBM) is to promote the emerging interdisciplinary field of nanomedicine. Nanomedicine: NBM is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.

Topics Covered (Recognized by AI)

BiologyChemistryMedicineMaterials ScienceGeneticsBiochemistryNanotechnologyPhysicsEngineeringOrganic ChemistryInternal MedicineQuantum MechanicsChemical EngineeringPharmacologyPsychologyImmunologyCell BiologyPathology

Primary Research Areas

Engineering & Technology Nanoscience & Nanotechnology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank64/191

IndexSCIE

JCRSCIE2026

NANOSCIENCE & NANOTECHNOLOGY

Rank79/148

IndexSCIE

JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Rank62/191

IndexSCIE

JCISCIE2026

NANOSCIENCE & NANOTECHNOLOGY

Rank51/148

IndexSCIE

Category	Index	Rank	Quartile
MEDICINE, RESEARCH & EXPERIMENTAL	JCRSCIE	64/191	Q2
NANOSCIENCE & NANOTECHNOLOGY	JCRSCIE	79/148	Q3
MEDICINE, RESEARCH & EXPERIMENTAL	JCISCIE	62/191	Q2
NANOSCIENCE & NANOTECHNOLOGY	JCISCIE	51/148	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF4.3

Articles / Year123

Total Citations41

2025

IF4.6

Articles / Year92

Total Citations194

2024

IF4.2

Articles / Year65

Total Citations357

2023

IF5.4

Articles / Year78

Total Citations1,078

2022

IF6.458

Articles / Year131

Total Citations2,153

Year	Impact Factor	Articles / Year	Total Citations
2026	4.3	123	41
2025	4.6	92	194
2024	4.2	65	357
2023	5.4	78	1,078
2022	6.458	131	2,153
2021	6.458	156	3,527
2020	5.182	181	5,004
2019	5.57	220	8,731
2018	6.5	562	9,733
2017	—	227	12,396
2016	—	628	13,376
2015	—	240	19,695

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,376Scopus Q1SCImago Profile

Scopus Coverage:2005-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyChemical EngineeringEngineeringMaterials ScienceMedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

0.845

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

4.97

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,275 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,502

3-Year Documents308

Citable Documents306

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate41.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ1

BioengineeringQ2

Biomedical EngineeringQ2

Materials Science (miscellaneous)Q2

Medicine (miscellaneous)Q2

Molecular MedicineQ2

Nanoscience and NanotechnologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

3区NANOSCIENCE & NANOTECHNOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Nanomedicine-Nanotechnology Biology and Medicine (acronym: nano, abbr: NANOMED-NANOTECHNOL, ISSN: 1549-9634) is a peer-reviewed international scholarly journal in the field of Engineering & Technology, published by Elsevier Inc. in Netherlands since 2005. The periodical holds a Journal Impact Factor (JIF) of 4.30, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.845 (Q1), an H-index of 166.

The journal enforces rigorous peer evaluation with an average review speed of 8.9周, a publication frequency of Quarterly, an annual output of approximately 143 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,275 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.